SPECT/CT hybrid imaging with 111In‐pentetreotide in assessment of neuroendocrine tumours (Q53638311)

16 May 2018

reason for preferred rank

title

SPECT/CT hybrid imaging with 111In‐pentetreotide in assessment of neuroendocrine tumours (English)

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

1 April 2024

SPECT/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616879

single-photon emission computed tomography

1 April 2024

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616879

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

1 April 2024

author name string

Yodphat Krausz

1

1 reference

16 May 2018

Zohar Keidar

2

1 reference

16 May 2018

Igor Kogan

3

1 reference

16 May 2018

Einat Even-Sapir

4

1 reference

16 May 2018

Rachel Bar-Shalom

5

1 reference

16 May 2018

Ahuva Engel

6

1 reference

16 May 2018

Rina Rubinstein

7

1 reference

16 May 2018

Jonathan Sachs

8

1 reference

16 May 2018

Moshe Bocher

9

1 reference

16 May 2018

Svetlana Agranovicz

10

1 reference

16 May 2018

Roland Chisin

11

1 reference

16 May 2018

Ora Israel

12

1 reference

16 May 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14616879

1 April 2024

publication date

1 November 2003

1 reference

16 May 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2265.2003.01885.x

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2265.2003.01885.x

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

1 April 2024

published in

Clinical Endocrinology

1 reference

16 May 2018

volume

59

1 reference

16 May 2018

issue

5

1 reference

16 May 2018

page(s)

565-573

1 reference

16 May 2018

Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01885.X

Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01885.X

Value of iterative reconstruction, attenuation correction, and image fusion in the interpretation of FDG PET images with an integrated dual-head coincidence camera and X-ray-based attenuation maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01885.X

Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01885.X

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01885.X

Somatostatin receptor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01885.X

Surgery to cure the Zollinger-Ellison syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01885.X

Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Somatostatin analog sandostatin and inhibition of tumor growth in patients with metastatic endocrine gastroenteropancreatic tumors

1 April 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies

1 April 2024

5

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Gamma camera-mounted anatomical X-ray tomography: technology, system characteristics and first images

1 April 2024

8

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Groupe D'etude Du Syndrome De Zollinger-Ellison

1 April 2024

9

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

1 April 2024

Carcinoid tumour

10

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Image analysis in patients with cancer studied with a combined PET and CT scanner

1 April 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Endosonography in decision making and management of gastrointestinal endocrine tumors

1 April 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasms

1 April 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their detection, frequency, location, and effect of their detection on management

1 April 2024

18

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study

1 April 2024

21

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Ability of somatostatin receptor scintigraphy to identify patients with gastric carcinoids: a prospective study

1 April 2024

22

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986.

1 April 2024

23

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems

1 April 2024

25

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison

1 April 2024

26

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors

1 April 2024

27

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results

1 April 2024

29

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Metastatic carcinoid tumors and the malignant carcinoid syndrome

1 April 2024

30

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors

1 April 2024

32

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Advances in the management of patients with Zollinger-Ellison syndrome.

1 April 2024

34

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Yttrium-90-labelled somatostatin-analogue for cancer treatment

1 April 2024

35

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging

1 April 2024

38

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management

1 April 2024

39

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Correlative image registration

1 April 2024

40

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study

1 April 2024

41

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Localization of adrenocorticotropic hormone-secreting bronchial carcinoid tumor by somatostatin-receptor scintigraphy

1 April 2024

42

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas

1 April 2024

43

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01885.X

1 April 2024

Identifiers

1 reference

16 May 2018

1 reference

16 May 2018